OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance
Assaf C. Bester, Jonathan D. Lee, Alejandro Chavez, et al.
Cell (2018) Vol. 173, Iss. 3, pp. 649-664.e20
Open Access | Times Cited: 276
Assaf C. Bester, Jonathan D. Lee, Alejandro Chavez, et al.
Cell (2018) Vol. 173, Iss. 3, pp. 649-664.e20
Open Access | Times Cited: 276
Showing 26-50 of 276 citing articles:
Dead Cas Systems: Types, Principles, and Applications
Sergey Brezgin, Anastasiya Kostyusheva, Dmitry Kostyushev, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6041-6041
Open Access | Times Cited: 101
Sergey Brezgin, Anastasiya Kostyusheva, Dmitry Kostyushev, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6041-6041
Open Access | Times Cited: 101
Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors
Orsolya Galamb, Barbara Kinga Barták, Alexandra Kalmár, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 34, pp. 5026-5048
Open Access | Times Cited: 100
Orsolya Galamb, Barbara Kinga Barták, Alexandra Kalmár, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 34, pp. 5026-5048
Open Access | Times Cited: 100
LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells
Xinke Wang, Zhixian Lan, Juan He, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 98
Xinke Wang, Zhixian Lan, Juan He, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 98
Systematic identification of non-coding pharmacogenomic landscape in cancer
Yue Wang, Zehua Wang, Jieni Xu, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 94
Yue Wang, Zehua Wang, Jieni Xu, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 94
Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance
Zi‐Qi Zheng, Zhi‐Xuan Li, Jia-Li Guan, et al.
Cancer Research (2020) Vol. 80, Iss. 23, pp. 5174-5188
Open Access | Times Cited: 92
Zi‐Qi Zheng, Zhi‐Xuan Li, Jia-Li Guan, et al.
Cancer Research (2020) Vol. 80, Iss. 23, pp. 5174-5188
Open Access | Times Cited: 92
Strategies to Annotate and Characterize Long Noncoding RNAs: Advantages and Pitfalls
Huifen Cao, Claes Wahlestedt, Philipp Kapranov
Trends in Genetics (2018) Vol. 34, Iss. 9, pp. 704-721
Closed Access | Times Cited: 85
Huifen Cao, Claes Wahlestedt, Philipp Kapranov
Trends in Genetics (2018) Vol. 34, Iss. 9, pp. 704-721
Closed Access | Times Cited: 85
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology
Xueli Tian, Tingxuan Gu, Satyananda Patel, et al.
npj Precision Oncology (2019) Vol. 3, Iss. 1
Open Access | Times Cited: 80
Xueli Tian, Tingxuan Gu, Satyananda Patel, et al.
npj Precision Oncology (2019) Vol. 3, Iss. 1
Open Access | Times Cited: 80
Ultrasound‐Augmented Nanocatalytic Ferroptosis Reverses Chemotherapeutic Resistance and Induces Synergistic Tumor Nanotherapy
Yi Zheng, Xin Li, Caihong Dong, et al.
Advanced Functional Materials (2021) Vol. 32, Iss. 4
Closed Access | Times Cited: 78
Yi Zheng, Xin Li, Caihong Dong, et al.
Advanced Functional Materials (2021) Vol. 32, Iss. 4
Closed Access | Times Cited: 78
CRISPR technologies for stem cell engineering and regenerative medicine
Mu‐Nung Hsu, Yu‐Han Chang, Vu Anh Truong, et al.
Biotechnology Advances (2019) Vol. 37, Iss. 8, pp. 107447-107447
Closed Access | Times Cited: 76
Mu‐Nung Hsu, Yu‐Han Chang, Vu Anh Truong, et al.
Biotechnology Advances (2019) Vol. 37, Iss. 8, pp. 107447-107447
Closed Access | Times Cited: 76
Reverse-genetics studies of lncRNAs—what we have learnt and paths forward
Fan Gao, Ye Cai, Philipp Kapranov, et al.
Genome biology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 70
Fan Gao, Ye Cai, Philipp Kapranov, et al.
Genome biology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 70
MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1
Qi‐Nian Wu, Xiao-Jing Luo, Jia Liu, et al.
Cancer Research (2021) Vol. 81, Iss. 10, pp. 2636-2650
Open Access | Times Cited: 62
Qi‐Nian Wu, Xiao-Jing Luo, Jia Liu, et al.
Cancer Research (2021) Vol. 81, Iss. 10, pp. 2636-2650
Open Access | Times Cited: 62
Micropeptide PACMP inhibition elicits synthetic lethal effects by decreasing CtIP and poly(ADP-ribosyl)ation
Chuanchao Zhang, Bo Zhou, Feng Gu, et al.
Molecular Cell (2022) Vol. 82, Iss. 7, pp. 1297-1312.e8
Open Access | Times Cited: 62
Chuanchao Zhang, Bo Zhou, Feng Gu, et al.
Molecular Cell (2022) Vol. 82, Iss. 7, pp. 1297-1312.e8
Open Access | Times Cited: 62
Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer
Xueman Chen, Rong Luo, Yunmei Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
Xueman Chen, Rong Luo, Yunmei Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
Exosomal long non-coding RNAs in cancer: Interplay, modulation, and therapeutic avenues
Rahaba Marima, Afra Basera, Thabiso Victor Miya, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 887-900
Open Access | Times Cited: 14
Rahaba Marima, Afra Basera, Thabiso Victor Miya, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 887-900
Open Access | Times Cited: 14
Modulating the expression of long non‐coding RNA s for functional studies
Siyuan Liu, Daniel A. Lim
EMBO Reports (2018) Vol. 19, Iss. 12
Open Access | Times Cited: 63
Siyuan Liu, Daniel A. Lim
EMBO Reports (2018) Vol. 19, Iss. 12
Open Access | Times Cited: 63
Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance
Yue Wang, Zihui Fang, Mei Hong, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 1, pp. 105-112
Open Access | Times Cited: 63
Yue Wang, Zihui Fang, Mei Hong, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 1, pp. 105-112
Open Access | Times Cited: 63
CRISPRai for simultaneous gene activation and inhibition to promote stem cell chondrogenesis and calvarial bone regeneration
Vu Anh Truong, Mu‐Nung Hsu, Nuong Thi Kieu Nguyen, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 13, pp. e74-e74
Open Access | Times Cited: 62
Vu Anh Truong, Mu‐Nung Hsu, Nuong Thi Kieu Nguyen, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 13, pp. e74-e74
Open Access | Times Cited: 62
A benchmark of algorithms for the analysis of pooled CRISPR screens
Sunil Bodapati, Timothy Daley, Xueqiu Lin, et al.
Genome biology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Sunil Bodapati, Timothy Daley, Xueqiu Lin, et al.
Genome biology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Functional Genomics for Cancer Drug Target Discovery
Benjamin Haley, Filip Roudnicky
Cancer Cell (2020) Vol. 38, Iss. 1, pp. 31-43
Open Access | Times Cited: 62
Benjamin Haley, Filip Roudnicky
Cancer Cell (2020) Vol. 38, Iss. 1, pp. 31-43
Open Access | Times Cited: 62
The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
Jingyi Wang, Chenzi Zhang, Bo Feng
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 6, pp. 3256-3270
Open Access | Times Cited: 52
Jingyi Wang, Chenzi Zhang, Bo Feng
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 6, pp. 3256-3270
Open Access | Times Cited: 52
Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing
Rongming Liu, Liya Liang, Emily F. Freed, et al.
Trends in biotechnology (2020) Vol. 39, Iss. 3, pp. 262-273
Open Access | Times Cited: 50
Rongming Liu, Liya Liang, Emily F. Freed, et al.
Trends in biotechnology (2020) Vol. 39, Iss. 3, pp. 262-273
Open Access | Times Cited: 50
Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance
Rana Shafabakhsh, Farzaneh Arianfar, Massoud Vosough, et al.
Cancer Gene Therapy (2021) Vol. 28, Iss. 12, pp. 1229-1255
Open Access | Times Cited: 47
Rana Shafabakhsh, Farzaneh Arianfar, Massoud Vosough, et al.
Cancer Gene Therapy (2021) Vol. 28, Iss. 12, pp. 1229-1255
Open Access | Times Cited: 47
Long Noncoding RNAs and Human Liver Disease
Johanna K. DiStefano, Glenn S. Gerhard
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 1-21
Open Access | Times Cited: 45
Johanna K. DiStefano, Glenn S. Gerhard
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 1-21
Open Access | Times Cited: 45
Long noncoding RNAs: A novel insight in the leukemogenesis and drug resistance in acute myeloid leukemia
Anuradha Kirtonia, Milad Ashrafizadeh, Ali Zarrabi, et al.
Journal of Cellular Physiology (2021) Vol. 237, Iss. 1, pp. 450-465
Closed Access | Times Cited: 45
Anuradha Kirtonia, Milad Ashrafizadeh, Ali Zarrabi, et al.
Journal of Cellular Physiology (2021) Vol. 237, Iss. 1, pp. 450-465
Closed Access | Times Cited: 45
Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
Yujun Park, An Na Seo, Jiwon Koh, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 43
Yujun Park, An Na Seo, Jiwon Koh, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 43
